{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T18:35:13Z","timestamp":1767724513691,"version":"build-2238731810"},"update-to":[{"DOI":"10.1002\/14651858.cd003870.pub5","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2017,8,22]],"date-time":"2017-08-22T00:00:00Z","timestamp":1503360000000}}],"reference-count":119,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2017,8,22]],"date-time":"2017-08-22T00:00:00Z","timestamp":1503360000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"},{"start":{"date-parts":[[2017,8,22]],"date-time":"2017-08-22T00:00:00Z","timestamp":1503360000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions"}],"content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd003870.pub6","type":"journal-article","created":{"date-parts":[[2017,8,22]],"date-time":"2017-08-22T12:51:22Z","timestamp":1503406282000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Oxycodone for cancer-related pain"],"prefix":"10.1002","volume":"2019","author":[{"given":"Mia","family":"Schmidt-Hansen","sequence":"first","affiliation":[{"name":"Royal College of Obstetricians and Gynaecologists; National Guideline Alliance; 27 Sussex Pl Regent's Park London UK NW1 4RG"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael I","family":"Bennett","sequence":"additional","affiliation":[{"name":"University of Leeds; Leeds Institute of Health Sciences; Charles Thackrah Building 101 Clarendon Road Leeds UK LS2 9LJ"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephanie","family":"Arnold","sequence":"additional","affiliation":[{"name":"Royal College of Obstetricians and Gynaecologists; 27 Sussex Place Regent's park London UK NW1 4RG"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nathan","family":"Bromham","sequence":"additional","affiliation":[{"name":"Royal College of Obstetricians and Gynaecologists; National Guideline Alliance; 27 Sussex Pl Regent's Park London UK NW1 4RG"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer S","family":"Hilgart","sequence":"additional","affiliation":[{"name":"National Collaborating Centre for Cancer; 2nd Floor, Park House, Greyfriars Road Cardiff Wales UK CF10 3AF"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2017,8,22]]},"reference":[{"issue":"1","key":"10.1002\/14651858.CD003870.pub6-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/S0022-3565(25)31396-0","article-title":"Analgesic studies of codeine and oxycodone in patients with cancer. I. Comparisons of oral with intramuscular codeine and of oral with intramuscular oxycodone","volume":"207","author":"Beaver","year":"1978","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"issue":"1","key":"10.1002\/14651858.CD003870.pub6-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0022-3565(25)31397-2","article-title":"Analgesic studies of codeine and oxycodone in patients with cancer. II. Comparisons of intramuscular oxycodone with intramuscular morphine and codeine","volume":"207","author":"Beaver","year":"1978","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"issue":"10","key":"10.1002\/14651858.CD003870.pub6-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"3222","DOI":"10.1200\/JCO.1998.16.10.3222","article-title":"Randomized, double-blind, cross-over trial comparing safety and efficacy of oral controlled-release oxycodone with controlled-release morphine in patients with cancer pain","volume":"16","author":"Bruera","year":"1998","journal-title":"Journal of Clinical Oncology"},{"key":"10.1002\/14651858.CD003870.pub6-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1200\/JCO.1999.17.2.730d","article-title":"Efficacy of controlled-release oxycodone","volume":"17","author":"Comerford","year":"1999","journal-title":"Journal of Clinical Oncology"},{"key":"10.1002\/14651858.CD003870.pub6-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1093\/annonc\/mdw097","article-title":"Are strong opioids equally effective and safe in the treatment of chronic cancer pain? A multicenter randomized phase IV 'real life' trial on the variability of response to opioids","volume":"27","author":"Corli","year":"2016","journal-title":"Annals of Oncology"},{"issue":"6","key":"10.1002\/14651858.CD003870.pub6-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1185\/030079904125003854","article-title":"Establishing the dosage equivalency of oxymorphone extended release and oxycodone controlled release in patients with cancer pain: a randomized controlled study","volume":"20","author":"Gabrail","year":"2004","journal-title":"Current Medical Research and Opinion"},{"key":"10.1002\/14651858.CD003870.pub6-BIB0007|cit7","unstructured":"Gabrail NY Dvergsten C Ma T Frailey A Ahdieh H Oxymorphone extended-release (ER) provides safe, effective, and rapid analgesia during opioid radiation: results of a randomized, double-blind, crossover, comparative study with oxycodone controlled-release (CR) [abstract] Proceedings of the American Society of Clinical Oncology 2003 737"},{"issue":"7","key":"10.1002\/14651858.CD003870.pub6-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1002\/(SICI)1097-0142(19970401)79:7<1428::AID-CNCR21>3.0.CO;2-0","article-title":"Comparative clinical efficacy and safety of a novel controlled-release oxycodone formulation and controlled-release hydromorphone in the treatment of cancer pain","volume":"79","author":"Hagen","year":"1997","journal-title":"Cancer"},{"issue":"1","key":"10.1002\/14651858.CD003870.pub6-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0304-3959(97)00072-9","article-title":"Controlled-release oxycodone and morphine in cancer related pain","volume":"73","author":"Heiskanen","year":"1997","journal-title":"Pain"},{"issue":"8","key":"10.1002\/14651858.CD003870.pub6-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1080\/02841860050215927","article-title":"Morphine or oxycodone in cancer pain?","volume":"39","author":"Heiskanen","year":"2000","journal-title":"Acta Oncologica"},{"key":"10.1002\/14651858.CD003870.pub6-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1185\/03007995.2013.831816","article-title":"Efficacy and safety of oral tapentadol extended release in Japanese and Korean patients with moderate to severe, chronic malignant tumor-related pain","volume":"29","author":"Imanaka","year":"2013","journal-title":"Current Medical Research and Opinion"},{"issue":"5","key":"10.1002\/14651858.CD003870.pub6-BIB0013|cit12","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1038\/clpt.1990.85","article-title":"Morphine and oxycodone hydrochloride in the management of cancer pain","volume":"47","author":"Kalso","year":"1990","journal-title":"Clinical Pharmacology and Therapeutics"},{"issue":"4","key":"10.1002\/14651858.CD003870.pub6-BIB0012|cit13","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1111\/j.1600-0773.1990.tb00838.x","article-title":"Morphine and oxycodone in the management of cancer pain: plasma levels determined by chemical and radioreceptor assays","volume":"67","author":"Kalso","year":"1990","journal-title":"Pharmacology & Toxicology"},{"issue":"10","key":"10.1002\/14651858.CD003870.pub6-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"3230","DOI":"10.1200\/JCO.1998.16.10.3230","article-title":"Comparison of controlled-release and immediate-release oxycodone tablets in patients with cancer pain","volume":"16","author":"Kaplan","year":"1998","journal-title":"Journal of Clinical Oncology"},{"issue":"11","key":"10.1002\/14651858.CD003870.pub6-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1038\/sj.bjc.6601365","article-title":"Comparison of sustained-release morphine with sustained-release oxycodone in advanced cancer patients","volume":"89","author":"Lauretti","year":"2003","journal-title":"British Journal of Cancer"},{"issue":"2","key":"10.1002\/14651858.CD003870.pub6-BIB0016|cit16","first-page":"296","article-title":"Pharmacokinetics and pharmacodynamics of oxycodone when given intravenously and rectally to adult patients with cancer pain","volume":"80","author":"Leow","year":"1995","journal-title":"Anesthesia and Analgesia"},{"issue":"11","key":"10.1002\/14651858.CD003870.pub6-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.1185\/03007995.2014.946126","article-title":"Clinical evaluation of the first oxycodone once daily prolonged release tablet in moderate to severe chronic pain: a randomized, double-blind, multicenter, cross-over, non-inferiority study to investigate efficacy and safety in comparison with an established oxycodone twice daily prolonged release tablet","volume":"30","author":"Lux","year":"2014","journal-title":"Current Medical Research and Opinion"},{"issue":"9","key":"10.1002\/14651858.CD003870.pub6-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1097\/AJP.0b013e3181ecd895","article-title":"Morphine versus oxycodone in pancreatic cancer pain: a randomized controlled study","volume":"26","author":"Mercadante","year":"2010","journal-title":"Clinical Journal of Pain"},{"issue":"3","key":"10.1002\/14651858.CD003870.pub6-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S1090-3801(98)90020-9","article-title":"Controlled-release oxycodone compared with controlled-release morphine in the treatment of cancer pain: A randomized, double-blind, parallel-group study","volume":"2","author":"Mucci-LoRusso","year":"1998","journal-title":"European Journal of Pain"},{"issue":"4","key":"10.1002\/14651858.CD003870.pub6-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0885-3924(98)00064-5","article-title":"The use of controlled-release oxycodone for the treatment of chronic cancer pain: a randomized, double-blind study","volume":"16","author":"Parris","year":"1998","journal-title":"Journal of Pain and Symptom Management"},{"issue":"2","key":"10.1002\/14651858.CD003870.pub6-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.jpainsymman.2014.05.021","article-title":"Morphine or oxycodone for cancer-related pain? A randomised, open-label, controlled trial","volume":"49","author":"Riley","year":"2015","journal-title":"Journal of Pain and Symptom Management"},{"issue":"4","key":"10.1002\/14651858.CD003870.pub6-BIB0022|cit22","first-page":"386","article-title":"A randomised controlled trial of oral morphine versus oral oxycodone for the treatment of pain in cancer patients","volume":"26","author":"Riley","year":"2012","journal-title":"Palliative Medicine"},{"issue":"4","key":"10.1002\/14651858.CD003870.pub6-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0885-3924(99)00079-2","article-title":"Can a controlled-release oral dose form of oxycodone be used as readily as an immediate-release form for the purpose of titrating to stable pain control?","volume":"18","author":"Salzman","year":"1999","journal-title":"Journal of Pain and Symptom Management"},{"issue":"2","key":"10.1002\/14651858.CD003870.pub6-BIB0024|cit24","first-page":"197","article-title":"Double-blind, randomized, two-period crossover efficacy and pharmacokinetic comparison of immediate-release oxycodone (IR) and controlled-release oxycodone (CR) in cancer patients with pain","volume":"61","author":"Stambaugh","year":"1997","journal-title":"Clinical Pharmacology and Therapeutics"},{"issue":"5","key":"10.1002\/14651858.CD003870.pub6-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1177\/00912700122010375","article-title":"Double-blind, randomized comparison of the analgesic and pharmacokinetic profiles of controlled- and immediate-release oral oxycodone in cancer pain patients","volume":"41","author":"Stambaugh","year":"2001","journal-title":"Journal of Clinical Pharmacology"},{"issue":"6","key":"10.1002\/14651858.CD003870.pub6-BIB0026|cit26","first-page":"444","article-title":"Observation of curative effects and adverse effects of oxycodone hydrochloride controlled-release tablets and fentanyl transdermal patches on the treatment of moderate or severe cancer pain","volume":"5","author":"Su","year":"2015","journal-title":"Anti-Tumor Pharmacy"},{"issue":"8","key":"10.1002\/14651858.CD003870.pub6-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.jpain.2014.04.008","article-title":"Safety and efficacy of once-daily hydromorphone extended-release versus twice-daily oxycodone hydrochloride controlled-release in Chinese patients with cancer pain: A phase 3, randomized, double-blind, multicenter study","volume":"15","author":"Yu","year":"2014","journal-title":"Journal of Pain"},{"issue":"6","key":"10.1002\/14651858.CD003870.pub6-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.jpainsymman.2016.05.030","article-title":"Comparison of the tolerability profile of controlled-release oral morphine and oxycodone for cancer pain treatment. An open-label randomized controlled trial","volume":"52","author":"Zecca","year":"2016","journal-title":"Journal of Pain and Symptom Management"},{"issue":"20","key":"10.1002\/14651858.CD003870.pub6-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"8797","DOI":"10.7314\/APJCP.2014.15.20.8797","article-title":"Pharmacoeconomics evaluation of morphone, MS Contin and oxycodone in the treatment of cancer pain","volume":"15","author":"Zhang","year":"2014","journal-title":"Asian Pacific Journal of Cancer Prevention"},{"issue":"1","key":"10.1002\/14651858.CD003870.pub6-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1177\/0269216311418869","article-title":"A randomized, double-blind, active-controlled, double-dummy, parallel-group study to determine the safety and efficacy of oxycodone\/naloxone prolonged-release tablets in patients with moderate\/severe, chronic cancer pain","volume":"26","author":"Ahmedzai","year":"2012","journal-title":"Palliative Medicine"},{"issue":"5","key":"10.1002\/14651858.CD003870.pub6-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"264","DOI":"10.5694\/mja11.10624","article-title":"Should opioids be used for chronic non-cancer pain?","volume":"195","author":"Awerbuch","year":"2011","journal-title":"Medical Journal of Australia"},{"key":"10.1002\/14651858.CD003870.pub6-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1185\/03007995.2011.586332","article-title":"Can morphine still be considered to be the standard for treating chronic pain? A systematic review including pair-wise and network meta-analyses","volume":"27","author":"Bekkering","year":"2011","journal-title":"Current Medical Research and Opinion"},{"issue":"11","key":"10.1002\/14651858.CD003870.pub6-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1038\/sj.bjc.6603162","article-title":"Controlled clinical trials in cancer pain. How controlled should they be? A qualitative systematic review","volume":"94","author":"Bell","year":"2006","journal-title":"British Journal of Cancer"},{"issue":"3","key":"10.1002\/14651858.CD003870.pub6-BIB0034|cit34","first-page":"337","article-title":"Use of opioids against severe cancer pain","volume":"124","author":"Borchgrevink","year":"2004","journal-title":"Tidsskrift for Den Norske Laegeforening"},{"key":"10.1002\/14651858.CD003870.pub6-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1177\/0269216310392102","article-title":"Is oral morphine still the first choice opioid for moderate to severe cancer pain? A systematic review within the European Palliative Care Research Collaborative guidelines project","volume":"25","author":"Caraceni","year":"2011","journal-title":"Palliative Medicine"},{"issue":"6","key":"10.1002\/14651858.CD003870.pub6-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/j.jpainsymman.2010.08.011","article-title":"Facial affect processing in patients receiving opioid treatment in palliative care: Preferential processing of threat in pain catastrophizers","volume":"41","author":"Carroll","year":"2011","journal-title":"Journal of Pain and Symptom Management"},{"issue":"6","key":"10.1002\/14651858.CD003870.pub6-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/0885-3924(94)90173-2","article-title":"The dose-response relationship of controlled-release codeine (Codeine Contin) in chronic cancer pain","volume":"9","author":"Chary","year":"1994","journal-title":"Journal of Pain and Symptom Management"},{"issue":"10","key":"10.1002\/14651858.CD003870.pub6-BIB0038|cit38","first-page":"920","article-title":"Efficacy and safety of oxycodone-acetaminophen for moderate and severe visceral pain in advanced cancer patients","volume":"18","author":"Chen","year":"2009","journal-title":"Chinese Journal of New Drugs"},{"issue":"7","key":"10.1002\/14651858.CD003870.pub6-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/0885-3924(91)90040-B","article-title":"A clinical study on the use of codeine, oxycodone, dextropropoxyphene, buprenorphine, and pentazocine in cancer pain","volume":"6","author":"Conno","year":"1991","journal-title":"Journal of Pain and Symptom Management"},{"issue":"7","key":"10.1002\/14651858.CD003870.pub6-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"A384","DOI":"10.1016\/j.jval.2013.08.357","article-title":"Quality of life benefits and cost impact of prolonged release oxycodone\/naloxone versus prolonged release oxycodone in patients with moderate to severe pain and opioid-induced constipation despite the use of 2 laxatives: A UK cost utility analysis","volume":"16","author":"Dunlop","year":"2013","journal-title":"Value in Health"},{"issue":"5","key":"10.1002\/14651858.CD003870.pub6-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1177\/0269216310392101","article-title":"A systematic review of combination step III opioid therapy in cancer pain: an EPCRC opioid guideline project","volume":"25","author":"Fallon","year":"2011","journal-title":"Palliative Medicine"},{"key":"10.1002\/14651858.CD003870.pub6-BIB0042|cit42","first-page":"viii363","article-title":"Randomized phase ii trial (NCT00637975) evaluating activity and toxicity of fixed dose of oxycodone and increasing dose of pregabalin versus increasing dose of oxycodone and fixed dose of pregabalin for the treatment of oncological neuropathic pain (neuropain-01)","volume":"21","author":"Garassino","year":"2010","journal-title":"Annals of Oncology"},{"issue":"15 Suppl 1","key":"10.1002\/14651858.CD003870.pub6-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"9028","DOI":"10.1200\/jco.2011.29.15_suppl.9028","article-title":"Final results of a randomized phase II trial (NCT00637975) evaluating activity and toxicity of fixed-dose oxycodone and increasing dose of pregabalin versus increasing dose of oxycodone and fixed-dose pregabalin for the treatment of oncologic neuropathic pain (NEUROPAIN-01)","volume":"29","author":"Garassino","year":"2011","journal-title":"Journal of Clinical Oncology. Conference: ASCO Annual Meeting"},{"issue":"4","key":"10.1002\/14651858.CD003870.pub6-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"e59981","DOI":"10.1371\/journal.pone.0059981","article-title":"Randomised phase II trial (NCT00637975) evaluating activity and toxicity of two different escalating strategies for pregabalin and oxycodone combination therapy for neuropathic pain in cancer patients","volume":"8","author":"Garassino","year":"2013","journal-title":"PloS One"},{"key":"10.1002\/14651858.CD003870.pub6-BIB0045|cit45","first-page":"HS7","article-title":"Oxycodone: Alternative therapy in the management of chronic cancer pain","volume":"51","author":"George","year":"2003","journal-title":"Cahiers d'Anesthesiologie"},{"key":"10.1002\/14651858.CD003870.pub6-BIB0046|cit46","first-page":"5","article-title":"Morphine and other opioids in the treatment of cancer pain?","volume":"13","author":"Hanks","year":"2002","journal-title":"International Journal of Cancer. Supplement = Journal International du Cancer. Supplement"},{"key":"10.1002\/14651858.CD003870.pub6-BIB0047|cit47","first-page":"790","article-title":"Compound matrine injection in liver carcinoma pain: A clinical study","volume":"28","author":"Hongmei","year":"2013","journal-title":"Journal of Gastroenterology and Hepatology"},{"issue":"5","key":"10.1002\/14651858.CD003870.pub6-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1089\/jpm.2015.0012.18.5","article-title":"Oxycodone frequently induced nausea and vomiting in oxycodone-naive patients with hepatic dysfunction","volume":"18","author":"Igarashi","year":"2015","journal-title":"Journal of Palliative Medicine"},{"issue":"9","key":"10.1002\/14651858.CD003870.pub6-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1097\/MLR.0b013e3181858edc","article-title":"Decreasing use of controlled-release oxycodone - Response","volume":"46","author":"Katz","year":"2008","journal-title":"Medical Care"},{"key":"10.1002\/14651858.CD003870.pub6-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s12904-015-0038-7","article-title":"Opioid rotation versus combination for cancer patients with chronic uncontrolled pain: a randomized study","volume":"14","author":"Kim","year":"2015","journal-title":"BMC Palliative Care"},{"key":"10.1002\/14651858.CD003870.pub6-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1177\/0269216311401948","article-title":"A systematic review of oxycodone in the management of cancer pain","volume":"25","author":"King","year":"2011","journal-title":"Palliative Medicine"},{"issue":"3 Suppl","key":"10.1002\/14651858.CD003870.pub6-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"ES39","DOI":"10.36076\/ppj.2012\/15\/ES39","article-title":"A systematic review of randomized trials on the effectiveness of opioids for cancer pain","volume":"15","author":"Koyyalagunta","year":"2012","journal-title":"Pain Physician"},{"issue":"1","key":"10.1002\/14651858.CD003870.pub6-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s00228-010-0893-3","article-title":"Effect of the inhibition of CYP3A4 or CYP2D6 on the pharmacokinetics and pharmacodynamics of oxycodone","volume":"67","author":"Kummer","year":"2011","journal-title":"European Journal of Clinical Pharmacology"},{"issue":"5","key":"10.1002\/14651858.CD003870.pub6-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/j.jpainsymman.2008.06.007","article-title":"Effectiveness of topical administration of opioids in palliative care: a systematic review","volume":"37","author":"LeBon","year":"2009","journal-title":"Journal of Pain and Symptom Management"},{"issue":"1","key":"10.1002\/14651858.CD003870.pub6-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/S1754-3207(11)70592-2","article-title":"Long-term efficacy and safety of the fixed combination oxycodone and naloxone prolonged release (PR) in patients with chronic cancer pain","volume":"5","author":"Leppert","year":"2011","journal-title":"European Journal of Pain Supplements"},{"issue":"18","key":"10.1002\/14651858.CD003870.pub6-BIB0056|cit56","first-page":"1619","article-title":"Therapeutic outcome of Tylox for cancer pain in malignant tumor patients with bone metastasis","volume":"17","author":"Li","year":"2008","journal-title":"Chinese Journal of New Drugs"},{"issue":"1","key":"10.1002\/14651858.CD003870.pub6-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1007\/s11670-010-0080-1","article-title":"Controlled-release oxycodone alone or combined with gabapentin for management of malignant neuropathic pain","volume":"22","author":"Li","year":"2010","journal-title":"Chinese Journal of Cancer Research"},{"issue":"15","key":"10.1002\/14651858.CD003870.pub6-BIB0058|cit58","first-page":"e3341","article-title":"The adverse events of oxycodone in cancer-related pain: a systematic review and meta-analysis of randomized controlled trials","volume":"95","author":"Ma","year":"2016","journal-title":"Medicine (Hagerstown)"},{"issue":"1","key":"10.1002\/14651858.CD003870.pub6-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.jpainsymman.2011.03.015","article-title":"Scrambler therapy may relieve chronic neuropathic pain more effectively than guideline-based drug management: Results of a pilot, randomized, controlled trial","volume":"43","author":"Marineo","year":"2012","journal-title":"Journal of Pain and Symptom Management"},{"issue":"2","key":"10.1002\/14651858.CD003870.pub6-BIB0060|cit60","first-page":"199","article-title":"Effectiveness observation on oxycodone hydrochloride controlled-release tablets for cancer pain","volume":"17","author":"Meng XT Xian Dai Zhong Xi Yi Jie He Za","year":"2008","journal-title":"Modern Journal of Integrated Traditional Chinese and Western Medicine"},{"issue":"1","key":"10.1002\/14651858.CD003870.pub6-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1001\/jama.1974.03230390031020","article-title":"Relief of pain by oral medications. A controlled evaluation of analgesic combinations","volume":"229","author":"Moertel","year":"1974","journal-title":"Journal of the American Medical Association"},{"key":"10.1002\/14651858.CD003870.pub6-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1007\/s00228-012-1228-3","article-title":"Serum concentrations of opioids when comparing two switching strategies to methadone for cancer pain","volume":"8","author":"Moksnes","year":"2012","journal-title":"European Journal of Clinical Pharmacology"},{"issue":"8","key":"10.1002\/14651858.CD003870.pub6-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1111\/j.1742-1241.2008.01820.x","article-title":"Patient assessment of a novel therapeutic approach for the treatment of severe, chronic pain","volume":"62","author":"Nadstawek","year":"2008","journal-title":"International Journal of Clinical Practice"},{"key":"10.1002\/14651858.CD003870.pub6-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"S74","DOI":"10.1016\/j.jpain.2013.01.632","article-title":"Lack of correlation between the dose of fentanyl sublingual spray for breakthrough cancer pain and the dose of around-the-clock opioid for persistent pain","volume":"1","author":"Nalamachu","year":"2013","journal-title":"Journal of Pain"},{"key":"10.1002\/14651858.CD003870.pub6-BIB0065|cit65","unstructured":"NCT01859715 Emergency department (ED) drug interaction in emergency department patients clinicaltrials.gov\/ct2\/show\/results\/NCT01859715"},{"key":"10.1002\/14651858.CD003870.pub6-BIB0066|cit66","unstructured":"NCT01885182 Targin cancer pain clinicaltrials.gov\/ct2\/show\/NCT01885182"},{"key":"10.1002\/14651858.CD003870.pub6-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1159\/000143225","article-title":"Oxycodone and the challenge of neuropathic cancer pain: a review","volume":"74","author":"Nunez Olarte","year":"2008","journal-title":"Oncology"},{"issue":"10","key":"10.1002\/14651858.CD003870.pub6-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/j.jpain.2015.05.006","article-title":"A systematic review of prospective studies reporting adverse events of commonly used opioids for cancer-related pain: a call for the use of standardized outcome measures","volume":"16","author":"Oosten","year":"2015","journal-title":"Journal of Pain"},{"issue":"18","key":"10.1002\/14651858.CD003870.pub6-BIB0069|cit69","first-page":"1767","article-title":"Efficacy of oxycodone-acetominophen by different administrations in controlling moderate to severe cancer pain and break-out pain","volume":"18","author":"Pang","year":"2009","journal-title":"Chinese Journal of New Drugs"},{"issue":"8","key":"10.1002\/14651858.CD003870.pub6-BIB0070|cit70","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1111\/pme.12431","article-title":"Aberrant drug-related behavior observed during a 12-week open-label extension period of a study involving patients taking chronic opioid therapy for persistent pain and fentanyl buccal tablet or traditional short-acting opioid for breakthrough pain","volume":"15","author":"Passik","year":"2014","journal-title":"Pain Medicine"},{"key":"10.1002\/14651858.CD003870.pub6-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1001\/archinte.166.8.837","article-title":"Oxycodone for cancer-related pain: Meta-analysis of randomized controlled trials","volume":"166","author":"Reid","year":"2006","journal-title":"Archives of Internal Medicine"},{"issue":"4","key":"10.1002\/14651858.CD003870.pub6-BIB0072|cit72","doi-asserted-by":"crossref","first-page":"371","DOI":"10.3111\/13696990903430481","article-title":"Validation of the Bowel Function Index to detect clinically meaningful changes in opioid-induced constipation","volume":"12","author":"Rentz","year":"2009","journal-title":"Journal of Medical Economics"},{"key":"10.1002\/14651858.CD003870.pub6-BIB0073|cit73","first-page":"1884","article-title":"Analgesic effect of oxycodone-acetaminophen tablets in patients with cervical cancer","volume":"17","author":"Shi","year":"2008","journal-title":"Chinese Journal of New Drugs"},{"issue":"15 Suppl 1","key":"10.1002\/14651858.CD003870.pub6-BIB0074|cit74","doi-asserted-by":"crossref","first-page":"e19691","DOI":"10.1200\/jco.2010.28.15_suppl.e19691","article-title":"Oxycodone\/acetaminophen addition to constant opioids in metastatic bone pain: A randomized, double-blinded, controlled, multicenter trial","volume":"28","author":"Sima","year":"2010","journal-title":"Journal of Clinical Oncology"},{"key":"10.1002\/14651858.CD003870.pub6-BIB0075|cit75","first-page":"378","article-title":"Oxycodone\/acetaminophen combination tablet in patients with metastatic bone pain: A randomized, double-blinded, placebo-controlled trial","volume":"21","author":"Sima","year":"2010","journal-title":"Annals of Oncology"},{"issue":"1","key":"10.1002\/14651858.CD003870.pub6-BIB0076|cit76","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1365-2710.2010.01239.x","article-title":"Efficacy of oxycodone\/paracetamol for patients with bone-cancer pain: a multicenter, randomized, double-blinded, placebo-controlled trial","volume":"37","author":"Sima","year":"2012","journal-title":"Journal of Clinical Pharmacy and Therapeutics"},{"issue":"4","key":"10.1002\/14651858.CD003870.pub6-BIB0077|cit77","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1002\/j.1552-4604.1980.tb01707.x","article-title":"Double-blind comparisons of zomepirac and oxycodone with aspirin phenacetin caffeine in cancer pain","volume":"20","author":"Stambaugh","year":"1980","journal-title":"Journal of Clinical Pharmacology"},{"issue":"2","key":"10.1002\/14651858.CD003870.pub6-BIB0078|cit78","first-page":"302","article-title":"Analgesic equivalence of Tylox\u00ae and Percodan\u00ae: Double-blind crossover study of patients with pain from malignancy","volume":"27","author":"Stambaugh","year":"1980","journal-title":"Current Therapeutic Research, Clinical and Experimental"},{"key":"10.1002\/14651858.CD003870.pub6-BIB0079|cit79","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1002\/j.1552-4604.1981.tb05657.x","article-title":"Analgesic efficacy of zomepirac sodium in patients with pain due to cancer","volume":"21","author":"Stambaugh","year":"1981","journal-title":"Journal of Clinical Pharmacology"},{"key":"10.1002\/14651858.CD003870.pub6-BIB0080|cit80","first-page":"458A","article-title":"A double-blind comparison of ibuprofen vs. placebo in reducing oxycodone-acetaminophen dosage in chronic cancer pain","volume":"33","author":"Stambaugh","year":"1985","journal-title":"Clinical Research"},{"key":"10.1002\/14651858.CD003870.pub6-BIB0081|cit81","first-page":"229","article-title":"Comparison of the efficacy and safety of oral xorphanol, acetaminophen\/oxycodone and placebo in chronic cancer pain","volume":"41","author":"Stambaugh","year":"1987","journal-title":"International Journal of Clinical Pharmacology and Therapeutics"},{"key":"10.1002\/14651858.CD003870.pub6-BIB0082|cit82","first-page":"187","article-title":"Comparison of flurbiprofen (Ansaid), oxycodone APAP and placebo in cancer pain, after single and repeat oral doses","volume":"47","author":"Stambaugh","year":"1990","journal-title":"Clinical Pharmacology and Therapeutics"},{"key":"10.1002\/14651858.CD003870.pub6-BIB0083|cit83","first-page":"151","article-title":"Multidose analgesic studies in chronic pain models","volume":"18","author":"Stambaugh","year":"1991","journal-title":"Advances in Pain Research and Therapy"},{"key":"10.1002\/14651858.CD003870.pub6-BIB0084|cit84","first-page":"47","article-title":"Extended release oxycodone. An oral opioid analgesic for cancer patients with chronic pain","volume":"85","author":"Taeron","year":"2002","journal-title":"Revue De L'Infirmiere"},{"issue":"1","key":"10.1002\/14651858.CD003870.pub6-BIB0085|cit85","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1177\/082585971302900108","article-title":"Intravesical baclofen, bupivacaine, and oxycodone for the relief of bladder spasm","volume":"29","author":"Wallace","year":"2013","journal-title":"Journal of Palliative Care"},{"issue":"2","key":"10.1002\/14651858.CD003870.pub6-BIB0086|cit86","doi-asserted-by":"crossref","first-page":"249","DOI":"10.3892\/etm.2012.571","article-title":"Efficacy and tolerability of oxycodone in moderate-severe cancer-related pain: A meta-analysis of randomized controlled trials","volume":"4","author":"Wang","year":"2012","journal-title":"Experimental and Therapeutic Medicine"},{"issue":"4","key":"10.1002\/14651858.CD003870.pub6-BIB0087|cit87","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1089\/jpm.2007.0176","article-title":"A randomized double-blind crossover comparison of continuous and intermittent subcutaneous administration of opioid for cancer pain","volume":"11","author":"Watanabe","year":"2008","journal-title":"Journal of Palliative Medicine"},{"key":"10.1002\/14651858.CD003870.pub6-BIB0088|cit88","first-page":"1432","article-title":"Safety and efficacy of oxycodone\/acetaminophen in treatment of moderate and advanced cancer pain","volume":"18","author":"Wu","year":"2009","journal-title":"Chinese Journal of Cancer Prevention and Treatment"},{"key":"10.1002\/14651858.CD003870.pub6-BIB0089|cit89","first-page":"112","article-title":"Application of controlled-release oxycodone and oral immediate-release morphine in the titration treatment of cancer pain","volume":"2","author":"Wu","year":"2015","journal-title":"Anti-Tumor Pharmacy"},{"key":"10.1002\/14651858.CD003870.pub6-BIB0090|cit90","first-page":"1877-9, 1900","article-title":"Efficacy and safety of oxycodone-acetaminophen tablet in 142 patients with different types of moderate and advanced cancer pain","volume":"21","author":"Xiong","year":"2008","journal-title":"Chinese Journal of New Drugs"},{"key":"10.1002\/14651858.CD003870.pub6-BIB0091|cit91","first-page":"859","article-title":"Treatment beginning with minute dose oxycontin with advanced stage cancer pain","volume":"6","author":"Xu","year":"2008","journal-title":"Modern Journal of Integrated Traditional Chinese and Western Medicine"},{"issue":"10","key":"10.1002\/14651858.CD003870.pub6-BIB0092|cit92","first-page":"923","article-title":"Efficacy of oxycodone-acetaminophen as an adjuvant of opioid analgesics for cancer pain","volume":"18","author":"Zou","year":"2009","journal-title":"Chinese Journal of New Drugs"},{"key":"10.1002\/14651858.CD003870.pub6-BIB0093|cit93","first-page":"103","article-title":"Evaluation of efficacy and safety of prolonged-release oxycodone at different dosages for the treatment of severe chronic pain","volume":"9","author":"Aurilio","year":"2009","journal-title":"Pain Practice"},{"issue":"4","key":"10.1002\/14651858.CD003870.pub6-BIB0094|cit94","first-page":"337","article-title":"Efficacies of oxycodone and morphine sulfate sustained-release tablets in treating moderate and severe cancer pain","volume":"18","author":"Song","year":"2009","journal-title":"Chinese Journal of New Drugs"},{"key":"10.1002\/14651858.CD003870.pub6-BIB0095|cit95","unstructured":"Long term opioid administration in oncologic chronic pain: open label, prospective study on efficacy, safety and pharmacogenetic factors Ongoing study"},{"key":"10.1002\/14651858.CD003870.pub6-BIB0096|cit96","unstructured":"Bukkaalinen fentanyyli sy\u00f6p\u00e4potilaiden toimenpidekivun hoidossa (\"The buccal fentanyl in cancer pain management measure\") Ongoing study"},{"issue":"15 Suppl 1","key":"10.1002\/14651858.CD003870.pub6-BIB0097|cit97","doi-asserted-by":"crossref","first-page":"TPS324","DOI":"10.1200\/jco.2010.28.15_suppl.tps324","article-title":"A randomized comparison of oral methadone as a \"first-switch\" opioid versus opioid switching between sustained-release morphine and oxycodone for oncology outpatients with pain management problems","volume":"28","author":"Elsayem","year":"2010","journal-title":"Journal of Clinical Oncology"},{"key":"10.1002\/14651858.CD003870.pub6-BIB0098|cit98","unstructured":"DS-7113b phase III study: A randomized double-blind comparison study with immediate release (IR) oxycodone in opioid-naive patients with cancer pain 2013"},{"key":"10.1002\/14651858.CD003870.pub6-BIB0099|cit99","unstructured":"Chronic Administration of Opioids in Cancer Chronic Pain:an Open Prospective Study on Efficacy, Safety and Pharmacogenetic Factors Influence Ongoing study February 2009"},{"key":"10.1002\/14651858.CD003870.pub6-BIB0100|cit100","unstructured":"A Randomized, Double-Blind, Active Controlled, Optimal Dose Titration, Multicenter Study to Evaluate the Safety and Efficacy of Oral JNS024 Extended Release (ER) in Japanese and Korean Subjects With Moderate to Severe Chronic Malignant Tumor Related Cancer Pain Ongoing study August 2012"},{"key":"10.1002\/14651858.CD003870.pub6-BIB0101|cit101","unstructured":"A Comparative Study of Immediate-Release Oxycodone Capsules Versus Immediate-Release Morphine Tablets for the Treatment of Chinese Patients With Cancer Pain. Ongoing study December 2010"},{"key":"10.1002\/14651858.CD003870.pub6-BIB0102|cit102","unstructured":"NCT02084355 Study of opioid rotation versus opioid escalation in patients with moderate to severe cancer pain clinicaltrials.gov\/ct2\/show\/NCT02084355"},{"key":"10.1002\/14651858.CD003870.pub6-BIB0103|cit103","unstructured":"Odanaka M Randomized study of fentanyl citrate versus oxycodone hydrochloride hydrate in patients with unresectable advanced pancreatic cancer upload.umin.ac.jp\/cgi-open-bin\/ctr\/ctr.cgi?function=brows&action=brows&type=summary&recptno=R000010996&language=J"},{"key":"10.1002\/14651858.CD003870.pub6-BIB0104|cit104","first-page":"303","article-title":"What evidence do we have that the WHO analgesic ladder is effective in cancer pain?","volume-title":"Systematic Reviews in Pain Research; Methodology Refined","author":"Bennett","year":"2008"},{"key":"10.1002\/14651858.CD003870.pub6-BIB0105|cit105","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1093\/annonc\/mdp001","article-title":"Cancer-related pain: a pan-European survey of prevalence, treatment, and patient attitudes","volume":"20","author":"Breivik","year":"2009","journal-title":"Annals of Oncology"},{"key":"10.1002\/14651858.CD003870.pub6-BIB0106|cit106","doi-asserted-by":"crossref","first-page":"e58","DOI":"10.1016\/S1470-2045(12)70040-2","article-title":"Use of opioid analgesics in the treatment of cancer pain: evidence based recommendations from the EAPC","volume":"13","author":"Caraceni","year":"2012","journal-title":"Lancet Oncology"},{"key":"10.1002\/14651858.CD003870.pub6-BIB0107|cit107","unstructured":"McMaster University, 2015 (developed by Evidence Prime, Inc.) GRADEpro Guideline Development Tool [Software] 2015"},{"issue":"36","key":"10.1002\/14651858.CD003870.pub6-BIB0108|cit108","doi-asserted-by":"crossref","first-page":"4149","DOI":"10.1200\/JCO.2014.56.0383","article-title":"Quality of cancer pain management: an update of a systematic review of under-treatment of patients with cancer","volume":"32","author":"Greco","year":"2014","journal-title":"Journal of Clinical Oncology"},{"key":"10.1002\/14651858.CD003870.pub6-BIB0109|cit109","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1016\/j.jpainsymman.2012.08.013","article-title":"Opioid therapies and cytochrome P450 interactions","volume":"44","author":"Gudin","year":"2012","journal-title":"Journal of Pain and Symptom Management"},{"key":"10.1002\/14651858.CD003870.pub6-BIB0110|cit110","unstructured":"Higgins JPT Green S editor(s) Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"key":"10.1002\/14651858.CD003870.pub6-BIB0111|cit111","unstructured":"Lefebvre C Manheimer E Glanville J Chapter 6: Searching for studies. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"key":"10.1002\/14651858.CD003870.pub6-BIB0112|cit112","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/S1734-1140(10)70316-9","article-title":"Role of oxycodone and oxycodone\/naloxone in cancer pain management","volume":"62","author":"Leppert","year":"2010","journal-title":"Pharmacological Report"},{"key":"10.1002\/14651858.CD003870.pub6-BIB0113|cit113","unstructured":"The Nordic Cochrane Centre, The Cochrane Collaboration Review Manager (RevMan) 2014"},{"key":"10.1002\/14651858.CD003870.pub6-BIB0114|cit114","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1002\/1097-0142(19870215)59:4<850::AID-CNCR2820590432>3.0.CO;2-1","article-title":"A validation study of the WHO method for cancer pain relief","volume":"59","author":"Ventafridda","year":"1987","journal-title":"Cancer"},{"key":"10.1002\/14651858.CD003870.pub6-BIB0115|cit115","unstructured":"World Health Organization (WHO) Cancer Pain Relief WHO, Geneva 1986"},{"issue":"11","key":"10.1002\/14651858.CD003870.pub6-BIB0116|cit116","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1097\/j.pain.0000000000000656","article-title":"Opioid prescribing for cancer patients in the last year of life: a longitudinal population cohort study","volume":"157","author":"Ziegler","year":"2016","journal-title":"Pain"},{"issue":"3","key":"10.1002\/14651858.CD003870.pub6-BIB0117|cit117","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003870.pub3","article-title":"Oxycodone for cancer-related pain","author":"Reid","year":"2010","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD003870.pub6-BIB0118|cit118","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1001\/jama.2015.8556","article-title":"Oxycodone for cancer pain in adult patients","volume":"314","author":"Schmidt-Hansen","year":"2015","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD003870.pub6-BIB0119|cit119","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1136\/bmjspcare-2017-001457","article-title":"Efficacy, tolerability and acceptability of oxycodone for cancer-related pain in adults: an updated Cochrane systematic review","volume":"8","author":"Schmidt-Hansen","year":"2018","journal-title":"BMJ Supportive & Palliative Care"}],"updated-by":[{"DOI":"10.1002\/14651858.cd003870.pub7","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2022,6,9]],"date-time":"2022-06-09T00:00:00Z","timestamp":1654732800000}}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cochranelibrary.com\/cdsr\/doi\/10.1002\/14651858.CD003870.pub6\/epdf\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,24]],"date-time":"2025-06-24T20:50:14Z","timestamp":1750798214000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD003870.pub6"}},"subtitle":[],"editor":[{"name":"Cochrane Pain, Palliative and Supportive Care Group","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2017,8,22]]},"references-count":119,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2019,3]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd003870.pub6","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,8,22]]}}}